THE ECOSYSTEM WE ARE BUILDING
Blue Forest is an early-stage venture
capital fund focused on deep tech.
We partner with founders building transformative
technologies that address complex global challenges.
Blue Forest Ventures is a venture capital firm founded in Berlin in 2024.
We focus on early-stage deep tech startups across Europe. The firm backs visionary founders building transformative technologies that address complex global challenges.
Blue Forest combines a structured, data-driven investment process powered by automation and advanced analytics with disciplined human judgment to bring greater rigor and consistency to early-stage investing.
We invest in early-stage deep tech startups.
In this context, our definition of deep tech encompasses all technological solutions based on scientific and/or engineering know-how that would be considered a significant improvement relative to the status quo.
We are not limited to specific subsectors or applications, and we invest in hardware as well as software solutions.
Our primary geographical focus is Europe, with potential for selective investments in Southeast Asia and North America.
We believe that innovation will play a decisive role in tackling some of the most existential challenges of our time. Our goal is to back visionary founders driving transformative technologies that ensure a better, sustainable future for all.
As former founders and operators we know that early-stage investing is often driven by instinct and informal networks. We believe it deserves more rigor.
Building breakthrough technology is hard. Raising capital should not depend on subjective bias or pattern recognition. Decision quality improves when structure, discipline, and analytical clarity are applied consistently.
We reduce bias through systematic evaluation processes where structure adds value, while preserving human discretion where qualitative assessment remains essential.
We believe sustainable performance in early-stage investing results from integrating structured systems with disciplined judgment rather than relying on either in isolation.
The science is rarely the problem for the startups we are interested in, as the founders are themselves experts in the field and often part of its most advanced research. Our core value add lies in our ability to bridge the gap between science and its commercialization. Like translators, we understand both sides.
